Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide funding lapse notice was added, informing users that information may not be up to date and that the NIH Clinical Center is open, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:47:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page. Capitalization updates were made to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag was updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T02:54:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 (Revision: v3.3.4 added; v3.3.3 removed). No substantive content or functionality of the study page is affected.
    Difference
    0.0%
    Check dated 2026-01-14T01:55:42.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing site locations (California, Kentucky, Maryland, Massachusetts, Ohio, Virginia) to the study page and reorganized location information. The HHS Vulnerability Disclosure link was removed and revision labels updated (v3.3.3 from v3.3.2).
    Difference
    0.6%
    Check dated 2025-12-23T10:21:09.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision line updated to v3.3.2, replacing the previous v3.3.1. This update does not alter study details, eligibility, or outcome data.
    Difference
    0.0%
    Check dated 2025-12-01T16:55:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; there are no changes to the study details, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:29:03.000Z thumbnail image

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.